The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Defense Verdict in Disability Discrimination Trial
Represented UnumProvident Corporation, a leading benefits provider worldwide, in a lawsuit in which the plaintiff claimed that he was discriminated more
Formation of PetroLiance LLC via merger of two oil companies
Represented PetroLiance LLC, an oil company, which was formed upon the closing of a multi-a multimillion dollar financing and the merger of Southern more
Synergistic Int’l, LLC v. Korman
Represented the owner of the GLASS DOCTOR mark in a trademark infringement suit against a company that had used the mark WINDSHIELD DOCTOR for 17 more
Construction litigation for architectural and engineering firm
Represented an architectural and engineering firm against the owner on claims arising from the construction of a $100 million plus kosher food more